AAAAAA

   
Results: 1-8 |
Results: 8
Growth advantage of chronic myeloid leukemia CFU-GM in vitro: survival to growth factor deprivation, possibly related to autocrine stimulation, is a more common feature than hypersensitivity to GM-CSF/IL3 and is efficiently counteracted by retinoids +/- alpha-interferon
Authors: Ferrero, D Foli, C Giaretta, F Argentino, C Rus, C Pileri, A
Citation: D. Ferrero et al., Growth advantage of chronic myeloid leukemia CFU-GM in vitro: survival to growth factor deprivation, possibly related to autocrine stimulation, is a more common feature than hypersensitivity to GM-CSF/IL3 and is efficiently counteracted by retinoids +/- alpha-interferon, LEUKEMIA, 15(3), 2001, pp. 422-429
Relationship between vascular enhancement, cerebral hemodynamics, and MR angiography in cases of acute stroke
Authors: Pantano, P Toni, D Caramia, F Falcou, A Fiorelli, M Argentino, C Fantozzi, LM Bozzao, L
Citation: P. Pantano et al., Relationship between vascular enhancement, cerebral hemodynamics, and MR angiography in cases of acute stroke, AM J NEUROR, 22(2), 2001, pp. 255-260
Overweight as an adverse prognostic factor for non-Hodgkin's lymphoma patients receiving high-dose chemotherapy and autograft
Authors: Tarella, C Caracciolo, D Gavarotti, P Argentino, C Zallio, F Corradini, P Novero, D Magnani, C Pileri, A
Citation: C. Tarella et al., Overweight as an adverse prognostic factor for non-Hodgkin's lymphoma patients receiving high-dose chemotherapy and autograft, BONE MAR TR, 26(11), 2000, pp. 1185-1191
Heparin versus aspirin in ischaemic stroke
Authors: Toni, D Argentino, C Fieschi, C
Citation: D. Toni et al., Heparin versus aspirin in ischaemic stroke, LANCET, 356(9228), 2000, pp. 504-504
Computed tomography findings in the first few hours of ischemic stroke: implications for the clinician
Authors: Fiorelli, M Toni, D Bastianello, S Sacchetti, ML Sette, G Falcou, A Argentino, C Lorenzano, S Di Angelantonio, E Bozzao, L
Citation: M. Fiorelli et al., Computed tomography findings in the first few hours of ischemic stroke: implications for the clinician, J NEUR SCI, 173(1), 2000, pp. 10-17
The burden of stroke: a need for stroke prevention
Authors: Argentino, C Prencipe, M
Citation: C. Argentino et M. Prencipe, The burden of stroke: a need for stroke prevention, PREVENTION OF ISCHEMIC STROKE, 2000, pp. 1-5
An analysis of which subgroups of multiple myeloma patients, divided according to beta(2)-microglobulin and plasma cell labeling index, benefit from high dose vs conventional chemotherapy
Authors: Boccadoro, M Tarella, C Palumbo, A Argentino, C Triolo, S Dominietto, A Callea, V Lauta, VM Molica, S Musto, P Marmont, F Gianni, AM Pileri, A
Citation: M. Boccadoro et al., An analysis of which subgroups of multiple myeloma patients, divided according to beta(2)-microglobulin and plasma cell labeling index, benefit from high dose vs conventional chemotherapy, HAEMATOLOG, 84(10), 1999, pp. 905-910
Dose-intensive melphalan with stem cell support (MEL100) is superior to standard treatment in elderly myeloma patients
Authors: Palumbo, A Triolo, S Argentino, C Bringhen, S Dominietto, A Rus, C Omede, P Tarella, C Pileri, A Boccadoro, M
Citation: A. Palumbo et al., Dose-intensive melphalan with stem cell support (MEL100) is superior to standard treatment in elderly myeloma patients, BLOOD, 94(4), 1999, pp. 1248-1253
Risultati: 1-8 |